Next Article in Journal
Gut Microbiota and Bile Acids Mediate the Clinical Benefits of YH1 in Male Patients with Type 2 Diabetes Mellitus: A Pilot Observational Study
Next Article in Special Issue
Scaffold Repurposing Reveals New Nanomolar Phosphodiesterase Type 5 (PDE5) Inhibitors Based on Pyridopyrazinone Scaffold: Investigation of In Vitro and In Silico Properties
Previous Article in Journal
Design of Hybrid Polymer Nanofiber/Collagen Patches Releasing IGF and HGF to Promote Cardiac Regeneration
Previous Article in Special Issue
Antiproliferative Copper(II) Complexes Bearing Mixed Chelating Ligands: Structural Characterization, ROS Scavenging, In Silico Studies, and Anti-Melanoma Activity
 
 
Article

Article Versions Notes

Pharmaceutics 2022, 14(9), 1856; https://doi.org/10.3390/pharmaceutics14091856
Action Date Notes Link
article xml file uploaded 2 September 2022 12:02 CEST Original file -
article xml uploaded. 2 September 2022 12:02 CEST Update https://www.mdpi.com/1999-4923/14/9/1856/xml
article pdf uploaded. 2 September 2022 12:02 CEST Version of Record https://www.mdpi.com/1999-4923/14/9/1856/pdf
article supplementary file uploaded. 2 September 2022 12:02 CEST - https://www.mdpi.com/1999-4923/14/9/1856#supplementary
article html file updated 2 September 2022 12:04 CEST Original file -
article html file updated 28 February 2023 12:02 CET Update https://www.mdpi.com/1999-4923/14/9/1856/html
Back to TopTop